Conflict of interest: Dr. Cho and Dr. Chan have served as sub investigators for Sanofi, Eli Lily, Abbvie, Pfizer, and Novartis and have received speaker fees from Sanofi, Eli Lilly, Abbvie, Pfizer, Viatris, and Novartis. Dr. Chu has served as an investigator for AbbVie, Amgen, Dermira, Janssen, Eli Lilly, Novartis, Oneness Biotech, Pfizer, Regeneron Pharmaceuticals Inc., Roche, and Sanofi; a consultant/advisory board member for AbbVie, Amgen, Eli Lilly, Novartis, Pfizer, Roche, Sanofi, and Viatris; and has received speaker fees from AbbVie, Eli Lilly, Janssen, Mylan, Novartis, Pfizer, Roche, Sanofi, and Viatris. Other authors have no conflict of interests.